ロード中...
Treatment of intestinal Behçet's syndrome with chimeric tumour necrosis factor α antibody
Few patients with Behçet's syndrome have gastrointestinal ulceration. Such patients are difficult to treat and have a higher mortality. Faced with refractory symptoms in two patients with intestinal Behçet's, we used the tumour necrosis factor α (TNF-α) monoclonal antibody infliximab to in...
保存先:
| 主要な著者: | , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2001
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1728519/ https://ncbi.nlm.nih.gov/pubmed/11600479 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/gut.49.5.725 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|